Standard cell panel screen - 2D OncoSignature™
Identify sensitive and resistant cell lines
- Pre-selected cancer cell lines (Horizon's library)
- Single therapeutic drug screening or combination drug screening
- Growth inhibition measure by ATP levels
Set up a drug screen
Interview with Dr David Sorrell, Cell Panel Screening Manager, Horizon
Discussing the importance of efficacious screens to aiding patient stratification -
'Power up your pipeline: maximizing single & combination screening for cancer’
Matrix combination screens
Find out the benefits of drug combination screening and how it helps improve cancer therapies.
Reveal the anti-proliferative signature of your drug
Use Horizon's screening services to identify sensitive or resistant cell lines to your drug
'Horizon's OncoSignature HT screening platform for the prediction of anticancer drug sensitivity'
Book a consultation with our screening experts
We're here to support informed decision making by providing:
- Collaborative approach
- Dedicated project manager
- Regular updates & interim data
- Detailed study report including raw data files and a free copy of our analysis workbench software
App note: Compound screening in BRCA2 (-/-) cell lines
Isogenic cells are a powerful and relevant tool for therapeutic discovery and development.
View our results from:
- Colony forming assay
- Proliferation assay